mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.0054 |
0.9 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |